Lastly, they demonstrated that IL-31 in CTCL patients is produced by specific T-cells (CD4+/CD26-), which express the skin-homing chemokine-receptor type-4 (CCR4). This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.